Sec. 138. Capital investment for domestic production

498 words·~2 min read·/bill/116/s/4629/is/section-138

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

In this section: The term company has the meaning given such term in section 847 of the National Defense Authorization Act for Fiscal Year 2020 ( Public Law 116–92 ). The term domestic means a company incorporated or formed in the United States— that is not under foreign ownership, control, or influence (FOCI); whose beneficial owners are United States persons; whose management are United States citizens; whose principal place of business is in the United States; and who is not— a foreign incorporated entity that is an inverted domestic corporation or any subsidiary of such entity; or any joint venture if more than 10 percent of the joint venture (by vote or value) is held by a foreign incorporated entity that is an inverted domestic corporation or any subsidiary of such entity.

To support the commercialization of federally funded research and development and the scaling of domestic production of critical technologies and supplies, there are authorized to be appropriated amounts as follows: For the National Security Innovation Capital program under section 230 of the John S. McCain National Defense Authorization Act for Fiscal Year 2019 ( Public Law 115–232 ; 10 U.S.C. 2358 note), including investment to scale domestic production of research and technology development of dual-use critical technologies, the following amounts:

For fiscal year 2021, $15,000,000. For fiscal year 2022, $16,050,000. For fiscal year 2023, $17,174,000. For fiscal year 2024, $18,376,000. For fiscal year 2025, $19,662,000. To carry out the Rapid Innovation Program

(RIP)under section 1073 of the Ike Skelton National Defense Authorization Act for Fiscal Year 2011 ( Public Law 111–383 ; 10 U.S.C. 2359a note), the following amounts: For fiscal year 2021, $250,000,000. For fiscal year 2022, $267,500,000. For fiscal year 2023, $286,250,000. For fiscal year 2024, $306,261,000. For fiscal year 2025, $327,699,000. To carry out title III of the Defense Production Act ( 50 U.S.C. 4531 et seq.), the following amounts: For fiscal year 2021, $100,000,000. For fiscal year 2022, $100,000,000. For fiscal year 2023, $200,000,000. For fiscal year 2024, $300,000,000. For fiscal year 2025, $300,000,000. To carry out the Industrial Base Analysis and Sustainment program under section 2508 of title 10, United States Code, the following amounts: For fiscal year 2021, $111,335,000. For fiscal year 2022, $119,128,000. For fiscal year 2023, $127,467,000. For fiscal year 2024, $136,390,000. For fiscal year 2025, $145,937,000. To carry out the Manufacturing Technology Program under subchapter IV of chapter 148 of title 10, United States Code, the following amounts: For fiscal year 2021, $140,080,000. For fiscal year 2022, $149,886,000. For fiscal year 2023, $160,378,000. For fiscal year 2024, $171,604,000. For fiscal year 2025, $183,616,000. The amounts authorized to be appropriated under paragraphs

(1)through

(5)of subsection

(b)shall supplement and not supplant amounts already appropriated for the purposes described in such paragraphs. The Secretary of Defense shall establish policies to focus funding authorized under this section to meet the needs of startup, small, and mid-sized companies in commercializing Federal research and development and scaling domestic manufacturing.

Connectionstraces to 5

Traces to 5 documents

public-private-law

U.S. Code

1 reference not yet in our index